Infratil Says CDC Data Centres Valuation Rises by A$448 Million
By David Winning
SYDNEY--New Zealand investment company Infratil said the value of its roughly 48% stake in the CDC Data Centres business has risen by 13% over the past six months.
Infratil said CDC is now worth between 3.641 billion Australian dollars (US$2.32 billion) and A$4.186 billion, representing a valuation gain of A$448 million through the end of March.
"CDC's data center design, operating model and customer base is strategically positioned to benefit from the new growth in demand for artificial intelligence services," said Chief Executive Jason Boyes. "These market dynamics have seen a significant uptick in inbound customer interest."
CDC is expecting a significant acceleration of construction and expansion of development planning in Canberra, Sydney, Melbourne and Auckland, he said.
CDC's net debt totaled A$2.27 billion at the end of September. Infratil said CDC continues to expect earnings before interest, tax, depreciation, amortization and financial derivative movements of between A$260 million and A$270 million in the 2024 fiscal year.
Write to David Winning at david.winning@wsj.com
(END) Dow Jones Newswires
October 08, 2023 16:04 ET (20:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
Morningstar’s Guide to Investing in Stocks
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst